Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Statin use and the risk of Alzheimer's disease: the MIRAGE study.

Green RC, McNagny SE, Jayakumar P, Cupples LA, Benke K, Farrer LA; MIRAGE Study Group.

Alzheimers Dement. 2006 Apr;2(2):96-103. doi: 10.1016/j.jalz.2006.02.003.

PMID:
19595865
2.

The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee.

Hendrie HC, Albert MS, Butters MA, Gao S, Knopman DS, Launer LJ, Yaffe K, Cuthbert BN, Edwards E, Wagster MV.

Alzheimers Dement. 2006 Jan;2(1):12-32. doi: 10.1016/j.jalz.2005.11.004.

PMID:
19595852
3.

Simvastatin-induced decline in cognition.

Padala KP, Padala PR, Potter JF.

Ann Pharmacother. 2006 Oct;40(10):1880-3. Epub 2006 Aug 29.

PMID:
16940411
5.

Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.

Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, Gureje O, Dickens J, Evans R, Smith-Gamble V, Unverzagt FW, Shen J, Hendrie H.

Neurology. 2006 Jan 24;66(2):223-7.

6.

Statins and cognitive function in the elderly: the Cardiovascular Health Study.

Bernick C, Katz R, Smith NL, Rapp S, Bhadelia R, Carlson M, Kuller L; Cardiovascular Health Study Collaborative Research Group.

Neurology. 2005 Nov 8;65(9):1388-94.

PMID:
16275825
7.

Effects of atorvastatin on inflammation and oxidative stress.

Sugiyama M, Ohashi M, Takase H, Sato K, Ueda R, Dohi Y.

Heart Vessels. 2005 Jul;20(4):133-6.

PMID:
16025360
8.

Statin use and the risk of incident dementia: the Cardiovascular Health Study.

Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, Newman AB, Hazzard WR, Zandi PP, Burke GL, Lyketsos CG, Bernick C, Kuller LH.

Arch Neurol. 2005 Jul;62(7):1047-51.

PMID:
16009757
9.

APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.

Dufouil C, Richard F, Fiévet N, Dartigues JF, Ritchie K, Tzourio C, Amouyel P, Alpérovitch A.

Neurology. 2005 May 10;64(9):1531-8.

PMID:
15883313
10.

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

Sparks DL, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C.

Arch Neurol. 2005 May;62(5):753-7.

PMID:
15883262
11.

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

Zandi PP, Sparks DL, Khachaturian AS, Tschanz J, Norton M, Steinberg M, Welsh-Bohmer KA, Breitner JC; Cache County Study investigators.

Arch Gen Psychiatry. 2005 Feb;62(2):217-24.

PMID:
15699299
12.

Alcohol consumption and cognition.

Evans DA, Bienias JL.

N Engl J Med. 2005 Jan 20;352(3):289-90. No abstract available.

PMID:
15659731
13.

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.

Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P; Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators.

N Engl J Med. 2005 Jan 6;352(1):29-38.

14.

C-reactive protein levels and outcomes after statin therapy.

Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators.

N Engl J Med. 2005 Jan 6;352(1):20-8.

15.

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

Li G, Higdon R, Kukull WA, Peskind E, Van Valen Moore K, Tsuang D, van Belle G, McCormick W, Bowen JD, Teri L, Schellenberg GD, Larson EB.

Neurology. 2004 Nov 9;63(9):1624-8.

PMID:
15534246
16.

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.

Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM.

Arch Neurol. 2004 May;61(5):668-72.

PMID:
15148142
17.

Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation.

Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK, Kjekshus JK.

Clin Cardiol. 2004 Apr;27(4):199-203.

18.

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

Collins R, Armitage J, Parish S, Sleight P, Peto R; Heart Protection Study Collaborative Group.

Lancet. 2004 Mar 6;363(9411):757-67.

PMID:
15016485
19.

Association between statin use and Alzheimer's disease.

Zamrini E, McGwin G, Roseman JM.

Neuroepidemiology. 2004 Jan-Apr;23(1-2):94-8.

PMID:
14739574
20.

Statin-associated memory loss: analysis of 60 case reports and review of the literature.

Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM.

Pharmacotherapy. 2003 Jul;23(7):871-80. Review.

PMID:
12885101

Supplemental Content

Support Center